Anxiety and Metabolic Disorders: The Role of Botanicals.

Hanna Trebesova, Valentina Orlandi, Raffaella Boggia, Massimo Grilli
Author Information
  1. Hanna Trebesova: Department of Pharmacy, University of Genoa, Viale Cembrano 4, 16148 Genoa, Italy. ORCID
  2. Valentina Orlandi: Department of Pharmacy, University of Genoa, Viale Cembrano 4, 16148 Genoa, Italy.
  3. Raffaella Boggia: Department of Pharmacy, University of Genoa, Viale Cembrano 4, 16148 Genoa, Italy. ORCID
  4. Massimo Grilli: Department of Pharmacy, University of Genoa, Viale Cembrano 4, 16148 Genoa, Italy. ORCID

Abstract

Anxiety and anxiety-related disorders are becoming more evident every day, affecting an increasing number of people around the world. Metabolic disorders are often associated with anxiety. Furthermore, anxiety branches into metabolic disorders by playing multiple roles as a cofactor, symptom, and comorbidity. Taken together, these considerations open the possibility of integrating the therapy of metabolic disorders with specific drugs for anxiety control. However, anxiolytic compounds often cause disabling effects in patients. The main goal could be to combine therapeutic protocols with compounds capable of reducing side effects while performing multiple beneficial effects. In this article we propose a group of bioactive ingredients called botanicals as a healthy supplement for the treatment of metabolic disorders related to anxiety.

Keywords

References

  1. J Am Coll Cardiol. 2018 Jul 3;72(1):96-118 [PMID: 29957236]
  2. Complement Ther Med. 2022 May;65:102802 [PMID: 35031435]
  3. Pharmaceuticals (Basel). 2021 Oct 02;14(10): [PMID: 34681242]
  4. Int J Environ Res Public Health. 2022 Mar 29;19(7): [PMID: 35409739]
  5. Phytother Res. 2021 Oct;35(10):5352-5364 [PMID: 34101925]
  6. Biosci Rep. 2021 Jun 25;41(6): [PMID: 34017975]
  7. Nutr Diabetes. 2020 Apr 27;10(1):14 [PMID: 32341338]
  8. Psychiatry Res. 2019 Jun;276:115-123 [PMID: 31075706]
  9. Int J Mol Sci. 2021 Apr 14;22(8): [PMID: 33919895]
  10. J Cell Mol Med. 2019 Jan;23(1):21-28 [PMID: 30450823]
  11. Future Med Chem. 2017 Jan;9(1):79-93 [PMID: 27995808]
  12. Sci Rep. 2021 Nov 25;11(1):22959 [PMID: 34824300]
  13. Front Med. 2020 Oct;14(5):564-582 [PMID: 32335802]
  14. Toxicol Appl Pharmacol. 2013 Nov 1;272(3):787-96 [PMID: 23954465]
  15. Nutrients. 2021 Dec 11;13(12): [PMID: 34959992]
  16. Curr Neuropharmacol. 2021;19(9):1468-1495 [PMID: 34254920]
  17. Physiol Res. 2018 Nov 14;67(5):795-808 [PMID: 30044120]
  18. Metab Syndr Relat Disord. 2021 Nov;19(9):469-482 [PMID: 34402660]
  19. Molecules. 2021 Mar 02;26(5): [PMID: 33801469]
  20. Br J Nutr. 2021 Dec 28;126(12):1771-1787 [PMID: 33618780]
  21. Chin J Integr Med. 2015 May;21(5):332-8 [PMID: 25776839]
  22. Mol Nutr Food Res. 2018 Jan;62(1): [PMID: 29127724]
  23. J Funct Morphol Kinesiol. 2021 Feb 11;6(1): [PMID: 33670194]
  24. Front Mol Neurosci. 2022 Feb 28;15:829886 [PMID: 35295707]
  25. Neurosci Biobehav Rev. 2019 Jul;102:13-23 [PMID: 31004628]
  26. Mediators Inflamm. 2016;2016:9340637 [PMID: 28003714]
  27. FEBS J. 2020 Mar;287(5):833-855 [PMID: 31955527]
  28. Evid Based Complement Alternat Med. 2018 Jun 19;2018:9041309 [PMID: 30018659]
  29. Front Pharmacol. 2022 Jan 17;12:819482 [PMID: 35111069]
  30. Microbiol Mol Biol Rev. 2017 Nov 8;81(4): [PMID: 29118049]
  31. Sci Rep. 2017 Oct 6;7(1):12770 [PMID: 28986580]
  32. Life Sci. 2019 May 15;225:8-19 [PMID: 30943382]
  33. Korean J Physiol Pharmacol. 2018 Mar;22(2):183-192 [PMID: 29520171]
  34. Medicines (Basel). 2019 Sep 09;6(3): [PMID: 31505825]
  35. Nutrients. 2021 Jul 12;13(7): [PMID: 34371888]
  36. Curr Neurol Neurosci Rep. 2017 Oct 17;17(12):94 [PMID: 29039142]
  37. Complement Ther Med. 2021 Mar;57:102642 [PMID: 33338583]
  38. Br J Pharmacol. 2020 Mar;177(6):1209-1211 [PMID: 32133625]
  39. J Anim Sci. 2021 Apr 1;99(4): [PMID: 33640974]
  40. Phytother Res. 2002 Nov;16(7):621-6 [PMID: 12410541]
  41. Molecules. 2021 Apr 12;26(8): [PMID: 33921464]
  42. Folia Morphol (Warsz). 2020;79(3):489-502 [PMID: 31724151]
  43. Molecules. 2020 Apr 23;25(8): [PMID: 32340373]
  44. J Endocrinol. 2021 Feb;248(2):133-143 [PMID: 33258801]
  45. Plants (Basel). 2021 Jul 30;10(8): [PMID: 34451620]
  46. Oxid Med Cell Longev. 2020 Jul 28;2020:5194508 [PMID: 32774676]
  47. Brain Behav Immun. 2020 Nov;90:403-419 [PMID: 32889082]
  48. Lancet. 2019 Jul 20;394(10194):240-248 [PMID: 31200992]
  49. J Neuroimmunol. 2019 Mar 15;328:98-104 [PMID: 30658292]
  50. Rev Lat Am Enfermagem. 2020 Oct 09;28:e3369 [PMID: 33053078]
  51. J Agric Food Chem. 2014 Jul 16;62(28):6535-8 [PMID: 24976365]
  52. Medicine (Baltimore). 2019 Mar;98(13):e15054 [PMID: 30921234]
  53. Nutrients. 2021 Jan 12;13(1): [PMID: 33445760]
  54. Nutrients. 2021 Oct 04;13(10): [PMID: 34684506]
  55. Eur J Pharmacol. 2013 Jun 15;710(1-3):49-58 [PMID: 23603526]
  56. Transl Psychiatry. 2021 Feb 4;11(1):97 [PMID: 33542178]
  57. Gastroenterology. 2021 Jan;160(2):573-599 [PMID: 33253685]
  58. Transl Psychiatry. 2019 Jan 31;9(1):57 [PMID: 30705252]
  59. J Pharm Biomed Anal. 2020 Jan 5;177:112820 [PMID: 31476432]
  60. J Ethnopharmacol. 2015 Aug 22;172:288-96 [PMID: 26144285]
  61. Curr Neuropharmacol. 2021;19(9):1401-1415 [PMID: 34102977]
  62. Drug Metab Rev. 2017 May;49(2):139-157 [PMID: 28290706]
  63. Nutrients. 2021 Feb 28;13(3): [PMID: 33671116]
  64. Nutrients. 2020 Apr 15;12(4): [PMID: 32326604]
  65. Foods. 2020 Sep 23;9(10): [PMID: 32977484]
  66. Mol Biol Rep. 2019 Oct;46(5):4709-4715 [PMID: 31218539]
  67. Indian J Physiol Pharmacol. 2006 Oct-Dec;50(4):409-15 [PMID: 17402272]
  68. Nutrients. 2020 Jun 18;12(6): [PMID: 32570937]
  69. Plants (Basel). 2021 Oct 20;10(11): [PMID: 34834596]
  70. Molecules. 2021 Jul 01;26(13): [PMID: 34279384]
  71. J Herb Pharmacother. 2006;6(2):31-41 [PMID: 17182483]
  72. Br J Pharmacol. 2017 Jun;174(11):1325-1348 [PMID: 27638428]
  73. Neurobiol Aging. 2020 Jan;85:74-82 [PMID: 31735378]
  74. J Evid Based Complementary Altern Med. 2017 Jan;22(1):96-106 [PMID: 27055824]
  75. Front Immunol. 2020 Oct 16;11:571731 [PMID: 33178196]
  76. Sci China Life Sci. 2015 Jun;58(6):564-9 [PMID: 25749423]
  77. Sci Rep. 2020 Aug 24;10(1):14112 [PMID: 32839473]
  78. Phytomedicine. 2017 Dec 1;36:168-175 [PMID: 29157811]
  79. J Nutr Biochem. 2022 Feb;100:108904 [PMID: 34748918]
  80. Sci Rep. 2021 Feb 8;11(1):3324 [PMID: 33558554]
  81. Mol Psychiatry. 2021 Jul;26(7):2837-2853 [PMID: 33767348]
  82. Br J Clin Pharmacol. 2018 Apr;84(4):659-672 [PMID: 29433155]
  83. Foods. 2019 May 30;8(6): [PMID: 31151279]
  84. Nutrients. 2020 Oct 29;12(11): [PMID: 33138077]
  85. Pharmacogn Mag. 2015 Oct;11(Suppl 3):S388-96 [PMID: 26929572]
  86. Prostaglandins Leukot Essent Fatty Acids. 2018 Sep;136:3-13 [PMID: 28314621]
  87. Molecules. 2021 Sep 09;26(18): [PMID: 34576959]
  88. Diabetes Res Clin Pract. 2022 Jun;188:109924 [PMID: 35584716]
  89. Nutrients. 2020 Jan 15;12(1): [PMID: 31952249]
  90. EFSA J. 2021 Dec 22;19(12):e06936 [PMID: 34987620]

Word Cloud

Created with Highcharts 10.0.0disordersanxietymetaboliceffectsAnxietyMetabolicoftenmultiplecompoundsbotanicalsanxiety-relatedbecomingevidenteverydayaffectingincreasingnumberpeoplearoundworldassociatedFurthermorebranchesplayingrolescofactorsymptomcomorbidityTakentogetherconsiderationsopenpossibilityintegratingtherapyspecificdrugscontrolHoweveranxiolyticcausedisablingpatientsmaingoalcombinetherapeuticprotocolscapablereducingsideperformingbeneficialarticleproposegroupbioactiveingredientscalledhealthysupplementtreatmentrelatedDisorders:RoleBotanicalsbudderivatesnutraceuticals

Similar Articles

Cited By